Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T99338 | Target Info | |||
Target Name | Stimulator of interferon genes protein (TMEM173) | ||||
Synonyms | Mediator of IRF3 activation; Endoplasmic reticulum interferon stimulator; ERIS | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TMEM173 | ||||
Biochemical Class | TMEM173 family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Vadimezan | Ligand Info | |||
Canonical SMILES | CC1=C(C2=C(C=C1)C(=O)C3=CC=CC(=C3O2)CC(=O)O)C | ||||
InChI | 1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19) | ||||
InChIKey | XGOYIMQSIKSOBS-UHFFFAOYSA-N | ||||
PubChem Compound ID | 123964 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4QXO Crystal structure of hSTING(group2) in complex with DMXAA | ||||||
Method | X-ray diffraction | Resolution | 1.88 Å | Mutation | Yes | [1] |
PDB Sequence |
SVAHGLAWSY
163 YIGYLRLILP173 ELQARIRTYN183 QHYNNLLRGA193 VSQRLYILLP203 LDCGVPDNLS 213 MADPNIRFRD223 MLPQQNIDRA233 GIKNRVYSNS243 VYELLENGQR253 AGTCVLEYAT 263 PLQTLFAMSQ273 YSQAGFSRED283 RLEQAKLFCR293 TLEDILADAP303 ESQNNCRLIA 313 YQEPADDSSF323 SLSQEVLRHL333 RQ
|
|||||
|
||||||
PDB ID: 4QXR Crystal structure of hSTING(S162A/G230I/Q266I) in complex with DMXAA | ||||||
Method | X-ray diffraction | Resolution | 2.37 Å | Mutation | Yes | [1] |
PDB Sequence |
SVAHGLAWAY
163 YIGYLRLILP173 ELQARIRTYN183 QHYNNLLRGA193 VSQRLYILLP203 LDCGVPDNLS 213 MADPNIRFLD223 KLPQQTIDRA233 GIKDRVYSNS243 IYELLENGQR253 AGTCVLEYAT 263 PLITLFAMSQ273 YSQAGFSRED283 RLEQAKLFCR293 TLEDILADAP303 ESQNNCRLIA 313 YQEPADDSSF323 SLSQEVLRHL333 RQ
|
|||||
|
||||||
PDB ID: 4QXQ Crystal structure of hSTING(S162A/Q266I) in complex with DMXAA | ||||||
Method | X-ray diffraction | Resolution | 2.42 Å | Mutation | Yes | [1] |
PDB Sequence |
SVAHGLAWAY
163 YIGYLRLILP173 ELQARIRTYN183 QHYNNLLRGA193 VSQRLYILLP203 LDCGVPDNLS 213 MADPNIRFLD223 KLPQQTGDRA233 GIKDRVYSNS243 IYELLENGQR253 AGTCVLEYAT 263 PLITLFAMSQ273 YSQAGFSRED283 RLEQAKLFCR293 TLEDILADAP303 ESQNNCRLIA 313 YQEPADDSSF323 SLSQEVLRHL333 RQ
|
|||||
|
||||||
PDB ID: 4QXP Crystal structure of hSTING(G230I) in complex with DMXAA | ||||||
Method | X-ray diffraction | Resolution | 2.51 Å | Mutation | Yes | [1] |
PDB Sequence |
SVAHGLAWSY
163 YIGYLRLILP173 ELQARIRTYN183 QHYNNLLRGA193 VSQRLYILLP203 LDCGVPDNLS 213 MADPNIRFLD223 KLPQQTIDRA233 GIKDRVYSNS243 IYELLENGQR253 AGTCVLEYAT 263 PLQTLFAMSQ273 YSQAGFSRED283 RLEQAKLFCR293 TLEDILADAP303 ESQNNCRLIA 313 YQEPADDSSF323 SLSQEVLRHL333 RQ
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .1YE or .1YE2 or .1YE3 or :31YE;style chemicals stick;color identity;select .A:159 or .A:162 or .A:163 or .A:166 or .A:167 or .A:240 or .A:263 or .A:264 or .A:266 or .A:267; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA. Cell Rep. 2014 Sep 25;8(6):1668-1676. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.